Techno Medica Amends Interim Audit Review Details

TOKYO, Aug 06 (Pulse News Wire) – Techno Medica CO.,LTD. (6678.T) amended part of its interim audit review statement for the first quarter of the fiscal year ending March 2027.

The correction was made due to errors identified in the previously published statement dated August 05, August 06, 2026. The amendment pertains specifically to the auditor's responsibility during the interim review process. Prior to the correction, the statement incorrectly indicated that the auditor’s conclusion would be based on their position throughout the interim period rather than solely within the interim review report.

Additionally, the revised version includes more detailed responsibilities related to obtaining evidence supporting conclusions on quarterly financial statements and reporting significant findings to the audit committee. Techno Medica stated that the corrections ensure accurate representation of the auditor's role and responsibilities in reviewing the company's financial statements. The changes clarify how auditors assess adherence to established standards and communicate important findings effectively.